45
total announcements
524824.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 04 Oct 2026
Market Cap
₹123 Cr
P/E (TTM)
49.5
EPS (TTM)
₹0.45
52W Low
₹15.20
52W High
₹45.31
Beta
0.70
Price / Book
0.5
Return on Equity
0.59%
Debt / Equity
23.1
Revenue (TTM)
₹270 Cr
Gross Margin
44.16%
Operating Margin
-0.74%
Bal Pharma Ltd
Bal Pharma Ltd's scrutinizer's report on postal ballot voting has been submitted, with no rejections or modifications received from shareholders after the issuance of a corrigendum. The voting process was conducted electronically, and the results will be considered as the final voting.
Bal Pharma Ltd
Bal Pharma Ltd has announced the outcome of its postal ballot, where the shareholders approved the issue of 10,00,000 Warrants to the Promoter on a preferential basis. The voting results showed 99.96% of the total votes received in favor of the resolution, with only 0.04% against it.
Bal Pharma Ltd
Bal Pharma Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the Unaudited (Standalone and Consolidated) Financial Statements for the first quarter ended 30th June 2026 and other general business matters.
Bal Pharma Ltd
Bal Pharma Ltd provides an opportunity to shareholders to submit comments on the corrigendum to the postal ballot notice within 48 hours.
Bal Pharma Ltd
Bal Pharma Ltd has issued a corrigendum to its postal ballot notice dated 09th July 2026, revising the issue price of warrants from ₹81/- to ₹84/- per warrant, including a premium of ₹74/- per warrant. The aggregate consideration for the proposed issue of 10,00,000 (Ten Lakh) warrants shall stand revised from ₹8,10,00,000/- to ₹8,40,00,000/-.